Shattuck Labs (STTK) Operating Expenses (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Operating Expenses of $15.5 million for Q1 2026, up 8.03% year-over-year from $14.4 million in Q1 2025, and up 16.26% quarter-over-quarter from $13.4 million in Q4 2025.
Shattuck Labs (STTK) Operating Expenses (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Operating Expenses for 8 consecutive years, with $15.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 8.03% year-over-year to $15.5 million; the TTM figure through Mar 2026 stood at $53.7 million (down 32.51% YoY), while the FY2025 annual figure was $52.5 million, down 39.15% from the prior year.
- Operating Expenses climbed to $15.5 million in Q1 2026 per STTK's latest filing, from $13.4 million in the prior quarter.
- Across five years, Operating Expenses topped out at $29.3 million in Q3 2023 and bottomed at $11.7 million in Q3 2025.
- Historically, Operating Expenses has averaged $20.7 million across 5 years, with a median of $21.2 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Expenses soared 64.47% — and 2025, when it slumped 46.96%.
- Shattuck Labs' Operating Expenses stood at $26.7 million in 2022, then dropped by 26.25% to $19.7 million in 2023, then fell by 0.12% to $19.6 million in 2024, then sank by 31.92% to $13.4 million in 2025, then advanced by 16.26% to $15.5 million in 2026.
- Business Quant data shows STTK's Operating Expenses at $15.5 million in Q1 2026, $13.4 million in Q4 2025, and $11.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | 16.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.16 Mn |
| Mar 31, 2026 | 15.55 Mn |
| Dec 31, 2025 | 13.37 Mn |
| Sep 30, 2025 | 11.72 Mn |
| Jun 30, 2025 | 13.03 Mn |
| Mar 31, 2025 | 14.39 Mn |
| Dec 31, 2024 | 19.64 Mn |
| Sep 30, 2024 | 20.92 Mn |
| Jun 30, 2024 | 24.57 Mn |
| Mar 31, 2024 | 21.16 Mn |
| Dec 31, 2023 | 19.67 Mn |
| Sep 30, 2023 | 29.28 Mn |
| Jun 30, 2023 | 22.95 Mn |
| Mar 31, 2023 | 21.72 Mn |
| Dec 31, 2022 | 26.67 Mn |
| Sep 30, 2022 | 25.44 Mn |
| Jun 30, 2022 | 27.71 Mn |
| Mar 31, 2022 | 24.17 Mn |
| Dec 31, 2021 | 20.83 Mn |
| Sep 30, 2021 | 19.48 Mn |